Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Sorafenib:MCnc:Pt:Ser/Plas:Qn

Known as: Sorafenib:Concentración de masa:Punto temporal:Suero o Plasma:Qn, Sorafénib:Masse/Volume:Ponctuel:Sérum/Plasma:Numérique, Sorafenib:KütlKons:Zml?:Ser/Plaz:Kant 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Objective Sorafenib is a recommended treatment for advanced hepatocellular carcinoma. The study is to evaluate the efficacy of… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2014
Highly Cited
2014
Exchange of extracellular cystine for intracellular glutamate by the antiporter system xc− is implicated in numerous pathologies… Expand
Review
2013
Review
2013
Objective: To examine real-world safety and treatment patterns of angiogenesis inhibitors for advanced renal cell carcinoma (aRCC… Expand